Literature DB >> 2965550

Papillon-Lefèvre syndrome. Ultrastructural study and successful treatment with acitretin.

V Nazzaro1, C Blanchet-Bardon, C Mimoz, J Revuz, A Puissant.   

Abstract

Four siblings affected by Papillon-Lefèvre syndrome (PLS) ranged in age from 2 to 11 years. The parents were unaffected and parental consanguinity was present. The 2-year-old girl showed the early manifestations of PLS; that is, slight gingival swelling and erythema occurring simultaneously with minimal scaling of palms and soles. The other siblings, aged 5, 8, and 11 years, showed severe periodontopathy with tooth loss and marked palmoplantar keratoderma with a centripetal extension of the keratoses to the limbs and trunk. These three older siblings were treated with acitretin (Ro 10-1670), the free acid of etretinate, with complete clearing of the skin and healing of gingival pockets. Treatment was given for 16 months; teeth that erupted during therapy were free of periodontopathy and remained firmly anchored to the alveolar bone. In two of the children ultrastructural examination of involved skin was performed before and during acitretin treatment. Before treatment a large number of lipidlike vacuoles were found in corneocytes and in granulocytes; tonofilaments were reduced in number, and keratohyaline granules frequently showed a rectangular or globular shape. During treatment with acitretin these abnormalities diminished markedly. Thus, etretin is effective in treating PLS and, if treatment is started at an early age, should allow patients with PLS to have normal adult dentition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2965550

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  4 in total

1.  Microbiological and serological investigations of oral lesions in Papillon-Lefèvre syndrome.

Authors:  V Clerehugh; D B Drucker; G J Seymour; P S Bird
Journal:  J Clin Pathol       Date:  1996-03       Impact factor: 3.411

2.  Long-Term Results after Placing Dental Implants in Patients with Papillon-Lefèvre Syndrome: Results 2.5-20 Years after Implant Insertion.

Authors:  Katrin Nickles; Mischa Krebs; Beate Schacher; Hari Petsos; Peter Eickholz
Journal:  J Clin Med       Date:  2022-04-26       Impact factor: 4.964

3.  Acitretin : A Review of its Pharmacology and Therapeutic Use.

Authors:  Tania Pilkington; Rex N Brogden
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

4.  Identification of novel mutation in cathepsin C gene causing Papillon-Lefèvre Syndrome in Mexican patients.

Authors:  José G Romero-Quintana; Luis O Frías-Castro; Eliakym Arámbula-Meraz; Maribel Aguilar-Medina; Jesús E Dueñas-Arias; Jesús D Melchor-Soto; José G Romero-Navarro; Rosalío Ramos-Payán
Journal:  BMC Med Genet       Date:  2013-01-11       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.